Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review

[1] Zuckerman DS(2008)Adjuvant therapy for pancreatic cancer: a review Cancer 112 243-249

[2] Ryan DP(2008)Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution Cancer Control. 15 288-294

[3] Helm JF(2010)Analysis of 5-year survivals after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma World J Surg 34 1908-1915

[4] Centeno BA(2016)Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios Surg Today 46 583-592

[5] Coppola D(2016)Trials of vaccines for pancreatic ductal adenocarcinoma: is there any hope of an improved prognosis? Surg Today 46 139-148

[6] Druta M(2008)Pancreatic adenocarcinoma: the actual 5-year survivors J Gastrointest Surg. 12 701-706

[7] Park JY(2014)Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas J Gastrointest Surg. 18 674-681

[8] Chen DT(2009)Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective J Surg Oncol 99 87-92

[9] Shimada K(2009)Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma Ann Surg Oncol 16 836-847

[10] Sakamoto Y(2004)Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors Am Coll Surg. 198 722-731

[1] Zuckerman DS(2008)Adjuvant therapy for pancreatic cancer: a review Cancer 112 243-249

[2] Ryan DP(2008)Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution Cancer Control. 15 288-294

[3] Helm JF(2010)Analysis of 5-year survivals after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma World J Surg 34 1908-1915

[4] Centeno BA(2016)Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios Surg Today 46 583-592

[5] Coppola D(2016)Trials of vaccines for pancreatic ductal adenocarcinoma: is there any hope of an improved prognosis? Surg Today 46 139-148

[6] Druta M(2008)Pancreatic adenocarcinoma: the actual 5-year survivors J Gastrointest Surg. 12 701-706

[7] Park JY(2014)Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas J Gastrointest Surg. 18 674-681

[8] Chen DT(2009)Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective J Surg Oncol 99 87-92

[9] Shimada K(2009)Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma Ann Surg Oncol 16 836-847

[10] Sakamoto Y(2004)Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors Am Coll Surg. 198 722-731